1 mg · vegan · gluten-free · 30 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
IGF-1 LR3 is a synthetic peptide analogue of Insulin-like Growth Factor 1, designed for enhanced stability and a longer duration of action. It is researched for its potential to promote tissue growth and repair, particularly within musculoskeletal tissues.
IGF-1 LR3 binds to IGF-1 receptors, stimulating cellular uptake of nutrients and promoting protein synthesis, chondrocyte proliferation, and osteoblast activity. This mechanism supports the repair and growth of cartilage, bone, and muscle tissue, leading to improved joint and musculoskeletal function.
Adults looking to address joint stiffness, muscle weakness, joint pain. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
C · C · emerging-to-moderate human evidence for joint and musculoskeletal health
SacredBod's longer take on IGF-1 LR3 — context the structured blocks above don't capture.
IGF-1 LR3 is a peptide supplement used to support joint and musculoskeletal health. Long-acting IGF-1 analogue researched for tissue growth. It is available in capsule form and dosed for adults in India and internationally. As a peptide-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol.
IGF-1 LR3 works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the joints, muscles, bones, and effects are dose-dependent, typically becoming measurable within 4-12 weeks for joint comfort. Consistency matters more than dose size for this category.
Adults looking to address joint stiffness, muscle weakness, joint pain. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
IGF-1 LR3 carries an evidence grade of C in the SacredBod catalog. Long-acting IGF-1 analogue researched for tissue growth. See the Research panel above for the underlying studies, participant counts and typical effect sizes.
Typical label dose is 1 mg in capsule form. Most adults can expect noticeable effects within 4-12 weeks for joint comfort. Consistency matters more than a single large dose — take it daily and re-evaluate against your blood markers at 8–12 weeks.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
As part of the Peptide category, IGF-1 LR3 can be used on its own or layered into a broader protocol — see the Goes with panel for synergistic pairings.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
Request received.
We'll route this to a clinician familiar with peptide protocols. Expect a reply within about 48 hours.
How's your experience? We read every note.
